HER2-expressing Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
HER2-expressing Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.364 enrolled15 locationsNCT06015048
Recruiting
Phase 3
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
Urothelial CarcinomaHER2-expressing
RemeGen Co., Ltd.452 enrolled2 locationsNCT05302284